Engineering collismycin biosynthesis enables potent acetylcholinesterase inhibitors
Collismycins suffer from limited structural diversity that restricts bioactivity exploration. Herein, we develop a bio-chemo-relay strategy combining biosynthetic engineering and chemical diversification to construct diverse collismycin analogues, affording a potent acetylcholinesterase inhibitor 4h with superior activity to galantamine.
Authors
- Runping Fang (ORCID: https://orcid.org/0000-0002-2904-1696)
- Fanyu Dong
- 润平 方 (ORCID: https://orcid.org/0000-0001-7712-8027)
- Weilong Liu (ORCID: https://orcid.org/0009-0001-4436-8451)
- Yanqing Li
- Changli Sun
- Jiyuan Yang
- Hongxu Liu
- Yanjun Song
- Yanqing Li
Institutions
- Shandong University (CN)
- Chinese Academy of Sciences (CN)
- South China Sea Institute Of Oceanology (CN)
- Suzhou Research Institute (CN)
- Shenzhen Technology University (CN)
- State Key Laboratory of Tropical Oceanography (CN)
Publication Details
- Journal
- Chemical Communications
- Published
- 2026-11-19
- DOI
- https://doi.org/10.1039/d6cc05733k
- Primary Topic
- Microbial Natural Products and Biosynthesis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Shandong University
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province
- Basic Research Program of Jiangsu Province